RxDoctor Payments Data

Jontu Solomon, MD

Family Medicine · Augusta, GANPI 1740701887

Payments from drug & device makers

$734in general payments, 2019–2025

Across 41 payments — averaging $17.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$163
  • Novo Nordisk$136
  • Lilly USA, LLC$117
  • AstraZeneca$77
  • Bayer$62
  • Amgen$51
  • plus $128 from 6 others

What the payments were for

  • Food & beverage$734100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$734 in reported general payments places this provider in the 50th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$72,294
Medicare patients
129
Services billed
1,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide167$215,215
JardianceEmpagliflozin101$101,733
EliquisApixaban74$64,049
RybelsusSemaglutide28$49,188
FarxigaDapagliflozin Propanediol26$29,611
MounjaroTirzepatide17$20,344
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$17,396
TradjentaLinagliptin18$11,788
SymbicortBudesonide/Formoterol Fumarate27$8,994
Tresiba Flextouch U-100Insulin Degludec13$8,944
Fluticasone-SalmeterolFluticasone Propion/Salmeterol29$6,767
Humalog Kwikpen U-100Insulin Lispro21$5,826
Gabapentin306$5,307
Albuterol Sulfate HfaAlbuterol Sulfate210$5,266
Advair HfaFluticasone Propion/Salmeterol12$5,023

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$136$264,403195 claims
Boehringer IngelheimJardiance, Tradjenta$43$113,521119 claims
PfizerEliquis, Dilantin$11$68,11885 claims
AstraZenecaFarxiga, Symbicort$77$38,60553 claims
Lilly USA, LLCMounjaro$117$20,34417 claims
GSKTrelegy Ellipta$16$17,39624 claims
AbbVieCreon$163$4,94211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →